Trial intelligence / Profile preview

Citalopram for central auditory processing impairment in older adults with hearing loss

ACTRN12614000570684Phase 4Completed

Sponsor
Jose Fernando Polanski
Start
Oct 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in Hypoacusis comparing Citalopram with Placebo (2 arms). Primary endpoint: Improvement in central auditory processing tests. Started Oct 2015; status: completed.

02

Drugs

citalopram
03

Conditions

Hypoacusis

Beyond the preview

Go deeper on ACTRN12614000570684.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12614000570684.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call